☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Reports the P-III (PALISADE) Trial Results of Plozasiran to Treat Familial Chylomicronemia Syndrome (FCS...
September 3, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.